Akihide Yoshimi

24PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Urban hydrologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 29, 2026
Multiplex Immunofluorescence-defined CXCL13-associated TLS-like Niches Predict Outcome in Bladder Cancer.

|Sep 13, 2026
Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer.

|Sep 07, 2026
Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives.

|Jul 17, 2026
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

|Jul 16, 2026
Norepinephrine-induced small GTPase RHOB mediates nocturnal intraocular pressure rise in mice.

|Feb 03, 2026
Advances in antisense oligonucleotide treatment for cancer.

Lu Zhu, Pariha Muhtar, Susumu Goyama

Pageof 4

Frequent Collaborators

4 joint publications

Omar Abdel-Wahab

4 joint publications

Takuya Tsujino

3 joint publications

Kazuki Nishimura

3 joint publications

Alessandro Pastore